In one of the largest med-tech deals to occur in 2013 so far, Thermo Fisher Scientific (Waltham, Massachusetts) said it plans to acquire Life Technologies (Austin, Texas) for $76 in cash per fully diluted common share, or about $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012).